Special Session of the World Health Assembly: Statement of Knowledge Ecology International

On Tuesday, 30 November 2021, Knowledge Ecology International (KEI) delivered the following statement during the special session of the World Health Assembly. Negotiators should address policy failures that have accompanied the current pandemic response, and create a better global framework… Continue Reading

WHO member countries agree on a pathway to draft and negotiate a convention, agreement or other international instrument on pandemic prevention, preparedness and response

After two weeks of intense negotiations, member states of the World Health Organization (WHO) have finally agreed to compromise text on a decision (The World Together: Establishment of an intergovernmental negotiating body to strengthen pandemic prevention, preparedness and response, SSA2/CONF./1)… Continue Reading

Silence procedure holds for the final report of the Member States Working Group on Strengthening WHO Preparedness for and Response to Health Emergencies (WGPR)

UPDATE: On Friday, 12 November 2021, the draft report of the Member States Working Group on Strengthening WHO Preparedness for and Response to Health Emergencies (WGPR) was published with the document number, A/WGPR/5/2. The report is available here. The fifth… Continue Reading

Zero Draft Report of the Member States Working Group on Strengthening WHO Preparedness for and Response to Health Emergencies (WGPR) charts a course for a potential pandemic treaty

Update: On 28 October 2021 the Zero Draft Report of the Member States Working Group on Strengthening WHO Preparedness for and Response to Health Emergencies to the special session of the World Health Assembly was published with the Document number… Continue Reading

KEI Comments on the Medicines Patent Pool/Merck License for Molnupiravir

(For more resources, please see our page on molnupiravir.) The Medicines Patent Pool (MPP) and Merck Sharp & Dohme (“MSD” or “Merck”) have announced a voluntary license for the generic manufacture and sale of molnupiravir. A joint press release from… Continue Reading

Countries included in the Merck/molnupiravir voluntary license with generic suppliers

(For more resources, please see our page on molnupiravir.) According to Brook Baker, these are the countries included in the Merck voluntary license to generic suppliers Afghanistan, Algeria, Angola, Bangladesh, Belize, Benin, Bhutan, Bolivia, Botswana, Burkina Faso, Burundi, Cambodia, Cameroon,… Continue Reading